![]() |
| Centres Turkey | |
| Prof. Hasan Yazici | |
| Personal | Hasan Yazici is the Chairman of the Department of Medicine and Chief of the Division of Rheumatology Unit, Cerrahpasa Medical Faculty, University of Istanbul, Turkey. Within his division, there are 2 fellows per year who train for 2 to 3 years |
| Interests |
Professor Yazici’s special clinical interests are Behçet’s syndrome, connective tissue diseases and clinical research methodology. Within the department, he has been running a specialised Behçet’s syndrome outpatient clinic for the past 30 years. The focus of his research has been mainly clinical aspects and drug studies related to Behçet’s syndrome. The team has also conducted research into various inflammatory and endothelium-derived factors in Behçet’s syndrome, usually using other rheumatic diseases as controls. This center would provide a suitable position for a fellow with a particular interest in Behçet’s syndrome, other vasculitides including Takayasu arteritis and auto-inflammatory diseases like familial Mediterranean fever. Further information is available at www.tuba.gov.tr |
| Research Projects |
1. Subspecialty based disease criteria |
| Recent Publications |
Hatemi G, Fresko I, Tascilar K, Yazici H. Increased enthesopathy among Behçet's syndrome patients with acne and arthritis: an ultrasonography study. Arthritis Rheum. 2008;58:1539-45. Yazici Y, Adler NM, Yazici H. Most tumour necrosis factor inhibitor trials in rheumatology are undeservedly called 'efficacy and safety' trials: a survey of power considerations. Rheumatology (Oxford).2008; 47:1054-7. Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gül A, Houmna MH, Kötter I, Olivieri I, Salvarani C, Sfikakis PP, Siva A, Stanford MR, Stübiger N Yurdakul S, Yazici H. EULAR recommendations for the management of Behcet's disease: report of a task force of the European Standing Committee for International Clinical Sstudies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2008;67:1656-62. Seyahi E, Ugurlu S, Cumali R, Balci H, Ozdemir O, Melikoglu M, Hatemi G, Fresko I, Hamuryudan V, Yurdakul S, Yazici H. Atherosclerosis in Behçet's Syndrome. Semin Arthritis Rheum. 2008; 38:1-12. Demirkesen C, Tüzüner N, Senocak M, Türkmen I, Aki H, Kepil N, Mat C, Yazici H. Comparative study of adhesion molecule expression in nodular lesions of Behçet syndrome and other forms of panniculitis. Am J Clin Pathol. 2008;130:28-33. Kiliç H, Zeytin HE, Korkmaz C, Mat C, Gül A, Coşan F, Dinç A, Simşek I, Süt N, Yazici H. Low-dose natural human interferon –alpha lozenges in the treatment of Behçet’s syndrome,. Rheumatology (Oxford). 2009;48:1388-91.
|
| close window | print page |